HMN 2025: How Age and disease duration are predictors of chronic kidney disease after stem cell transplant

Age, disease duration are predictors of CKD after stem cell transplant

Predictors of chronic kidney disease (CKD) include age and hematologic disease length after hematopoietic stem cell transplantation (HSCT), according to a study published online Aug. 4 in Renal Failure.

Alina Tanase, M.D., Ph.D., from Fundeni Clinical Institute in Bucharest, Romania, and colleagues prospectively assessed a cohort of 197 patients (mean age, 38.7 years; 52.8% female) who underwent allogeneic HSCT to explore the incidence and associated with CKD.

Overall, was present in 80% of patients within three months, and CKD incidence was 11.7% (median onset, six months). The researchers found that age (per year) was the only variable associated with CKD by univariate Cox regression analysis (hazard ratio [HR], 1.06); a trend of association was presented for baseline creatinine (per 1 mg/dL). Positive predictors for CKD included age (per year; HR, 1.08) and hematologic disease length (per month; HR, 1.01) in a multivariate Cox regression analysis. Acute lymphoblastic leukemia was a negative predictive factor (HR, 0.37).

“Given the continuously improving oncologic prognosis of these patients, CKD is becoming a challenge in the long-term care after HSCT, compelling for a multidisciplinary approach,” the authors write.

More information:
Alina Tanase et al, Incidence and risk factors for chronic kidney disease after hematopoietic stem cell transplantation, Renal Failure (2025). DOI: 10.1080/0886022X.2025.2535517

2025 HealthDay.

Citation:
Age and disease duration are predictors of chronic kidney disease after stem cell transplant ( 12)
14
age-disease-duration-predictors-chronic.html

The content is provided for information purposes only.